Mechanism of Action - The Central Command Override
- Central Action: Primarily act on α2-adrenergic receptors in the brainstem (nucleus tractus solitarii).
- Sympathetic Reduction: This stimulation mimics a negative feedback loop, leading to ↓ sympathetic outflow from the CNS.
- Peripheral Effects:
- Results in decreased norepinephrine (NE) release at peripheral nerve endings.
- Leads to ↓ peripheral vascular resistance and ↓ cardiac output, thus lowering blood pressure.
⭐ Abrupt discontinuation, especially of clonidine, can cause severe rebound hypertension and tachycardia due to a surge in sympathetic activity.
Indications & Contraindications - Green Lights & Red Flags
Indications (Green Lights ✅)
- Hypertension: Primarily for resistant HTN. Methyldopa is a choice for pregnancy-induced hypertension.
- ADHD: Guanfacine and Clonidine serve as non-stimulant treatment options.
- Symptom Management (Clonidine):
- Opioid & nicotine withdrawal symptoms.
- Menopausal hot flashes.
- Tourette syndrome tics.
Contraindications (Red Flags 🚫)
- Abrupt Discontinuation: ⚠️ High risk of severe rebound hypertension and tachycardia. Must taper dose slowly.
- Elderly Patients: Increased risk of CNS effects and orthostatic hypotension (Beers List).
- Depression: Can cause or exacerbate depressive symptoms.
⭐ Methyldopa is a key choice for hypertension in pregnancy but is famously associated with drug-induced lupus and hemolytic anemia (positive Coombs test).
Adverse Effects - The Rebound & Sedation Show
-
Central Nervous System (CNS): The most frequent, dose-dependent effects.
- Sedation, fatigue, and dizziness.
- Depression can occur, limiting use in susceptible patients.
-
Cardiovascular System:
- ⚠️ Rebound Hypertension: Abrupt withdrawal is critical to avoid. It leads to a surge in sympathetic outflow, causing severe ↑BP, tachycardia, and nervousness. Always taper the dose slowly over several days.
- Bradycardia and orthostatic hypotension.
-
Other Common Effects:
- Dry mouth (xerostomia) and constipation.
- Sodium and water retention, often resulting in edema.
⭐ Methyldopa-Specific: Can cause a positive Coombs test in up to 20% of patients, which may lead to hemolytic anemia. It can also induce hepatitis or a lupus-like syndrome.
Key Agents - Clonidine, Guanfacine, Methyldopa
| Feature | Clonidine | Guanfacine | Methyldopa |
|---|---|---|---|
| Primary Use | HTN, ADHD, Tourette's | HTN, ADHD | HTN in Pregnancy |
| α2 Selectivity | Less selective | More selective (vs α1) | Acts as false neurotransmitter |
| Key Side Effect | Rebound HTN upon abrupt cessation | Less sedation & rebound HTN | Drug-induced lupus, +Coombs test |
| Clinical Pearl | Useful for opioid/nicotine withdrawal sx | Longer half-life than clonidine | Safe in pregnancy |
⭐ Methyldopa can cause a positive Coombs test, sometimes leading to hemolytic anemia. It's a classic exam question linking a drug to a specific autoimmune-like reaction.
High‑Yield Points - ⚡ Biggest Takeaways
- Mechanism: Centrally acting α2-agonists that ↓ sympathetic outflow from the brainstem, leading to reduced blood pressure.
- Clonidine is used for hypertensive urgency and ADHD; abrupt discontinuation causes severe rebound hypertension.
- α-Methyldopa is a first-line agent for hypertension in pregnancy.
- Key side effects of methyldopa include drug-induced lupus and Coombs-positive hemolytic anemia.
- Common adverse effects for the class include sedation, dry mouth, and bradycardia.
Unlock the full lesson and continue reading
Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more
